Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$205,302
-$32,323 QoQ
Shares Held
1,625
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,902
of 2,266 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEATHERLY ASSET MANAGEMENT L. P. holds $338,223,820 across 8 Drug Manufacturers - General names. GILD ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
271,656 | $325,832,383 | |
| 2 | JNJ |
Johnson & Johnson
|
26,996 | $6,856,174 | |
| 3 | ABBV |
AbbVie Inc.
|
9,830 | $2,473,621 | |
| 4 | AMGN |
Amgen Inc
|
4,045 | $1,464,775 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,839 | $750,311 | |
| 6 | NVS |
Novartis AG
|
2,621 | $410,763 | |
| 7 | SNY |
Sanofi
|
5,403 | $230,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,625 | $205,302 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,302 | 1,625 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $237,625 | 1,705 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $206,571 | 1,683 | Shares | Sole | 2026-01-16 | |
| 2025-06-30 | $208,989 | 1,885 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $206,396 | 1,842 | Shares | Sole | 2025-05-01 | |
| 2020-06-30 | $201,967 | 2,625 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||